Table 3. Study results.
| CF patients (n = 35) | |||
|---|---|---|---|
| sputum samples | available (n = 23) | not available (n = 12) | |
| MABSC sputum culture | positive (n = 4(5*)) | negative (n = 18) | na |
| DNA-strip test (pos/neg) | 4/1 | 0/18 | na |
| MABSC rpo-qPCR (pos/neg) | 4/1 | 0/18 | na |
| MABSC immune test (pos/neg) | 5/0 | 2/16 | 3/9 |
* One CF patient (CF002) had a history of previous MABSC infection but an unclear infection status at study onset due to persistent culture contamination. For sputum PCR analyses this patient was classified as MABSC negative (confirmed by our assays). n: number of patients; na: not applicable; pos: positive; neg: negative.